CompletedNot Applicable

18F-FDG Tomography and Labeled Leukocyte Scintigraphy

France18 participantsStarted 2020-12-18

Plain-language summary

The study will aim to show that there is a superiority of 18F-FDG PET/CT compared to labeled leukocyte scintigraphy in patients with a malignant otitis externa.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with malignant otitis externa who received a 18F-FDG positron emission tomography and a labelled leukocyte scintigraphy Exclusion Criteria: * patients who refuse to have their imaging data used

What they're measuring

18F-FDG positron emission tomography

Timeframe: one day

Labeled leukocyte scintigraphy

Timeframe: one day

Trial details

NCT IDNCT05994768

SponsorCentral Hospital, Nancy, France

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-07-12

View on ClinicalTrials.gov More Malignant Otitis Externa trials